165 related articles for article (PubMed ID: 24698978)
1. Distinct pathways leading to TDP-43-induced cellular dysfunctions.
Yamashita M; Nonaka T; Hirai S; Miwa A; Okado H; Arai T; Hosokawa M; Akiyama H; Hasegawa M
Hum Mol Genet; 2014 Aug; 23(16):4345-56. PubMed ID: 24698978
[TBL] [Abstract][Full Text] [Related]
2. [The molecular mechanisms of intracellular TDP-43 aggregates].
Nonaka T; Arai T; Hasegawa M
Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
[TBL] [Abstract][Full Text] [Related]
3. [Intracellular seeded aggregation of TDP-43].
Nonaka T; Hasegawa M
Rinsho Shinkeigaku; 2012; 52(11):1056-8. PubMed ID: 23196514
[TBL] [Abstract][Full Text] [Related]
4. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD.
Tamaki Y; Urushitani M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293362
[TBL] [Abstract][Full Text] [Related]
5. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.
Nonaka T; Arai T; Buratti E; Baralle FE; Akiyama H; Hasegawa M
FEBS Lett; 2009 Jan; 583(2):394-400. PubMed ID: 19111550
[TBL] [Abstract][Full Text] [Related]
7. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
[TBL] [Abstract][Full Text] [Related]
8. Prion-like properties of pathological TDP-43 aggregates from diseased brains.
Nonaka T; Masuda-Suzukake M; Arai T; Hasegawa Y; Akatsu H; Obi T; Yoshida M; Murayama S; Mann DM; Akiyama H; Hasegawa M
Cell Rep; 2013 Jul; 4(1):124-34. PubMed ID: 23831027
[TBL] [Abstract][Full Text] [Related]
9. Distinct molecular patterns of TDP-43 pathology in Alzheimer's disease: relationship with clinical phenotypes.
Tomé SO; Vandenberghe R; Ospitalieri S; Van Schoor E; Tousseyn T; Otto M; von Arnim CAF; Thal DR
Acta Neuropathol Commun; 2020 Apr; 8(1):61. PubMed ID: 32349792
[TBL] [Abstract][Full Text] [Related]
10. An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice.
Walker AK; Tripathy K; Restrepo CR; Ge G; Xu Y; Kwong LK; Trojanowski JQ; Lee VM
Hum Mol Genet; 2015 Dec; 24(25):7241-54. PubMed ID: 26476406
[TBL] [Abstract][Full Text] [Related]
11. Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation.
Nagata E; Nonaka T; Moriya Y; Fujii N; Okada Y; Tsukamoto H; Itoh J; Okada C; Satoh T; Arai T; Hasegawa M; Takizawa S
Mol Neurobiol; 2016 Oct; 53(8):5377-83. PubMed ID: 26440668
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD.
Yamashita T; Teramoto S; Kwak S
Neurosci Res; 2016 Jun; 107():63-9. PubMed ID: 26723245
[TBL] [Abstract][Full Text] [Related]
13. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43.
Nonaka T; Kametani F; Arai T; Akiyama H; Hasegawa M
Hum Mol Genet; 2009 Sep; 18(18):3353-64. PubMed ID: 19515851
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
[TBL] [Abstract][Full Text] [Related]
15. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Takeda T
Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
[TBL] [Abstract][Full Text] [Related]
16. TDP-43-induced death is associated with altered regulation of BIM and Bcl-xL and attenuated by caspase-mediated TDP-43 cleavage.
Suzuki H; Lee K; Matsuoka M
J Biol Chem; 2011 Apr; 286(15):13171-83. PubMed ID: 21339291
[TBL] [Abstract][Full Text] [Related]
17. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
18. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
Ratti A; Buratti E
J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
[TBL] [Abstract][Full Text] [Related]
19. Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation.
Watabe K; Kato Y; Sakuma M; Murata M; Niida-Kawaguchi M; Takemura T; Hanagata N; Tada M; Kakita A; Shibata N
Neuropathology; 2020 Dec; 40(6):570-586. PubMed ID: 32686212
[TBL] [Abstract][Full Text] [Related]
20. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
